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Abstract. The consumption of feeds contaminated with mycotoxins (particularly aflatoxins,
ochratoxin A, zearalenone) by the animals causes various hepatic and renal; disorders, severe
immunodeficiency, reproductive disorders and the presence of these mycotoxins or their metabolites in
various fluids (such as aflatoxin M1, metabolite of aflatoxin B1). Various studies have determined the
presence of aflatoxin M1 and of zearalenone in milk, of aflatoxin B1 in the hepatic tissue and in the
serum, of ochratoxin A in the liver, of zearalenone in the bile; the presence of these mycotoxins in
different organs depends on the selective place of metabolisation of these mycotoxins. The research
aimed to determine the aflatoxins (AFB1, AFB2 and AFM1), ochratoxin (OTA) and zearalenone (ZEA)
in some biological fluids (milk, ruminal fluid, urine and bile) collected from bovids (cows and sheep),
using ELISA and CSS techniques. The results have shown the presence of mycotoxin metabolites in all
the analysed matrices, with values between 0 (below the detection limit) and 2.23 ppb for total AF in the
ruminal fluid; 25.06 ppb for OTA in the ruminal fluid; 42 ppt for AFM1 in milk and absence of
mycotoxins AFB1, AFB2 and ZEA in the samples of urine and bile.
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INTRODUCTION
Presently, the kinetics of transformations and the risk associated to the ingestion and
absorption of aflatoxins is well established, both in animals and in humans. The main route
for aflatoxin conjugation is glucuronoconjugation, the complex resulting from this process
being eliminated through the bile. The liver is the target organism for aflatoxins. At this level,
mycotoxin metabolisation takes place under the action of the microsomal enzymes. The
reaction products are eliminated from the organism through the excretion products (faeces and
urine) and through milk, unmodified and as metabolites.
In vitro studies have shown that over 90% of ZEA is degraded in the rumen by the
ruminal microsymbionts, with the production of α-zearalenol (Kiessling et al., 1984),
compound which is four times more estrogenic than the parental toxin, and with the
production of β-zearalenol, toxic compound for the endometrial cells (Tiemann et al., 2003).
The highest rate of transformation of ZEA in metabolism products was noticed for the first
time at incubation  (Moschini et al., 1999), the protozoa playing an important role in this
transformation (Kiessling et al., 1984). ZEA is transformed, in lower amounts, in zeranol (α-
zearalanol) too, through a process of hydrogenation of the α-zearalenol, the end product being
detected in the rumen and in the bile too (Kennedy et al., 1998). ZEA can also be metabolised
in the rumen and liver, with the formation of zearalenol, compound which is not toxic for the
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ruminal bacteria which degrade the mycotoxins. This supports the almost full metabolisation
of this mycotoxin within the dairy cows’ organism.
OTA is absorbed passively, unionized, from the digestive tract, particularly from the
small intestine, at a pH of 7.04. After OTA gets into the organism, it binds to plasma
albumins and starts to get metabolised quite rapidly, function of the animal species. OTA
displays the highest affinity for the liver and kidneys. At the hepatic level, OTA is
metabolised by hydroxylation into 4-hydroxyochratoxin A, metabolite eliminated via the
renal pathway (Krogh, 1992; Ruhland et al., 1996). Another important metabolite, OT-α,
forms in the digestive tract, where it is subsequently absorbed, and eliminated via the
digestive and renal pathways. Other metabolites that are formed in the organism follow an
entero-hepatic circuit after which they are eliminated through the faeces or urine (Curtui,
1998).
An important aspect of OTA metabolisation in the organism is its renal; absorption in
the proximal tubules (2/3), in the distal tubules and in the collecting duct (1/3). This
phenomenon takes place because of the disturbed pH homeostasis of the nephron cell walls,
which affects the trans-epithelial acid-alkali transportation and determines urine acidification.
Urine acidification favours OTA reabsorption, which makes the mycotoxin build up in the
organism by decreasing its rate of removal (Gekle and Silbernagl, 1996).
The purpose of the research was to determine the aflatoxin, ochratoxin and zearalenone
from some biological fluids collected from bovids (cows and sheep).
MATERIALS AND METHODS
The laboratory techniques used to determine these mycotoxins are different, from
immunoenzyme screening to liquid chromatography or liquid chromatography coupled with
mass spectrometry. The immunoenzymatic technique (ELISA) is usually used in Romania to
detect the mycotoxins from biological fluids. The principle of this method is to couple the
antigen with the antibody in the presence of the substrate coupled with an enzyme. A
peculiarity for zearalenone detection is that when the mycotoxin is detected in a specific
concentration, that sample will also be analysed for zeranolol presence because of the crossed
reactions that may develop between these two substance with a very similar chemical structure.
Because the maximal admitted limits for mycotoxins in the biological fluids are
regulated by European regulations only for milk (maxim 50ng/kg in fresh milk, according to
EC 1881/2006), the mycotoxin (aflatoxins B1, ochratoxin A, zearalenone) level must be
monitored constantly in other biological matrices as well.
The purpose of the research was to analyse by ELISA aflatoxin M1 (AFM1), aflatoxin
B1 (AFB1) and zearalenone (ZEA) in milk (48 samples), urine (3 samples), ruminal fluid (10
samples) and bile (11 samples) collected from bovids in various counties and localities
throughout Romania.
The biological fluids were collected in sterile containers, observing the hygiene rules
and the acting regulations (SR RN ISO 707/2002 for milk). The samples were transported




For total AF, AFB1 and OTA determination in the ruminal fluid, samples were
collected from 10 cows whose forages were documented for the presence of mycotoxins.
Table 1 shows the results of the analysis.
Tab. 1.
Total AF, AFB1 and OTA levels in the ruminal fluid






1 ruminal fluid 2.17
2 ruminal fluid 2.23
3 ruminal fluid 2.21
4 ruminal fluid 0.98
5 ruminal fluid 0.99
6 ruminal fluid 0.98
7 ruminal fluid (diluted with distilled water) 25.06
8 ruminal fluid (non diluted) 23.91
9 ruminal fluid (diluted with buffer solution) 34.61*
10 ruminal fluid (non diluted) 24.98
Limits of variation 2.17-2.23 0.98-0.99 23.91-25.06
Positive analyses. no./% 3 100.0 3 100.0 4 100.0
Total analyses. no./% 3 100.0 3 100.0 4 100.0
* result not relevant
The analysis of Table 1 results shows that:
- total AF were determined in 100% cases (3 samples), with variation limits between
2.1 – 2.2 ppb in the three analysed samples;
- AFB1 was determined in 100% cases (3 samples), with variation limits between 0.98
– 0.99 ppb in the three analysed samples.
The presence of AF and its metabolites in the ruminal fluid was reported in many
scientific papers. Contradictory results were reported in relation with AFB1 biodegradation in
the rumen. Some researchers observed a significant decrease of the initial AFB1 concentration
when it was incubated with ruminal fluid, while others didn’t report this phenomenon
(Kiessling et al., 1984). Generally, the ruminal degradability of AFB1 is minor and the
toxicity of its metabolites is similar with that of the parent molecule.
Auerbach et al. (1998b) notices that the addition of 9.5 ng AFB1/ml ruminal fluid
didn’t alter in vitro alfalfa digestion and didn’t influence the VFA production, while in
another study, the addition of 1 µg AFB1/ml decreased the rumen capacity to produce volatile
fatty acids. In vivo studies have also reported the presence of AFM1 in the ruminal content,
which takes us to the conclusion that the AFM1 produced in the liver may get back to the
rumen via the rumen-hepatic route (Auerbach et al., 1998a).
AF affects the ruminal function by reducing the ruminal motility, the capacity of fibre
digestion, the capacity of VFA production and the proteolysis capacity (Cook et al., 1986).
The ruminal fluid and particularly the bacterial population from the rumen of the cows and
sheep don’t have the capacity to convert AF into other metabolites, except for AFM1
metabolite which was detected in large amounts in the milk.
OTA was determined in 100% cases (4 samples), with variation limits between 23.91
(non diluted sample) and 25.06 (the sample diluted with distilled water) ppb in three of the
four analysed samples; the value of 34.61 ppb in one sample (sample diluted with buffer
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solution) was not considered relevant, possibly because of the influence of the solution on the
composition of the fluid.
In vitro study that after the ruminal fluid was incubated, 60% of the ingested OTA was
degraded to OTA-α. Protozoa are judged to play a major role in OTA degradation to OTA-α.
(Diaz, 2005). Müller et al., (1995) evaluated by in vitro studies that the adult cows are able to
degrade 33 to 72 mg OTA/day, and the sheep, 3 to 7 mg OTA/day.
The food composition influences the structure of the ruminal microsymbionts and
implicitly the capacity to degrade OTA. When the mycotoxin is found in large amounts in the
diet, the microbial capacity of detoxification is low and ochratoxicosis symptoms appear.
OTA metabolism on the rumen is much lower when a higher amount of concentrated feeds is
ingested than when the diet consists mainly of fibrous feeds (Xiao et al., 1991a, 1991b).
The research also analysed 48 milk samples collected from bovids reared in 18
counties and localities (Bacău, Botoşani, Brăila, Bucureşti, Buzău, Călăraşi, Constanţa,
Covasna, Dâmboviţa, Giurgiu, Ialomiţa, Ilfov, Olt, Pantelimon, Suceava, Vaslui and
Vrancea). The samples were analysed by ELISA for AFM1 (with LOD 5 ppt). The results
show the presence of the mycotoxin in 16.66% of the cases (8 samples), with limits of
variation between 0 - 42 ppt, while in 41.66% of the cases (40 samples) AFM1 was not
detected by analysis.
Other research has shown that after the oral administration of AFB1, the metabolites
are rapidly found in the urine and milk, while small amounts can be detected in the faeces,,
which supports the fast absorption of AFB1 in the digestive tractul and its hepatic metabolism.
In the dairy cows, of the total 4.52% AF detected in the organism, 1.55% was traced in
urine, 2.79% in the faeces and 0.18% in the milk, as AFM1 which means 0.35% of the given
dose. In the lactating ewes, of the 8.1% of the ingested amount, 6.4% was detected in the
urine, 1.6% in the faeces, and 0.1% in the milk. After 6 days from administration, AF was no
longer detected in the milk, after 8 days in the urine and after 9 days in the faeces (250).
The presence of mycotoxins AFB1 (ELISA, LOD 0.5 ppb), AF B2 (CSS 1 ppb) and
ZEA (ELISA, LOD 0.05 ppb) in urine was ascertained on a sample of urine collected from a
bovid from Brăila County, which was analysed by ELISA for ZEA, on a sample of urine from
a bovid from Botoşani County, which was analysed by ELISA for AFB1 and by CSS for
AFB2, and on a sample of urine from a bovid from Buzău County, which was analysed by
ELISA for ZEA. The results were negative for all analyses, none of these mycotoxins being
detected using the specified methods.
The studies of distribution and metabolism of C14 marked AFB1 in the organism of
animals, have shown both the elimination of significant amounts of the mycotoxin during the
first 24 hours and the build up of residual amounts in various organs (muscle, stomach, liver,
heart, etc.), build up which depends on the amount of ingested mycotoxin. The lipophilic
mycotoxins with a molecular mass lower than that of AFB1 are absorbed in the digestive tract
through passive diffusion.
After the administration of a total dose of 300 mg AF (0.5 mg AF/kg) we evaluated
the metabolism and level of AF distribution in the body of the dairy cows and lactating ewes.
AF identification in the excretion products using CSS revealed that 85% of the total ingested
AF was excreted in the cows and 90% in the sheep within 48 hours from ingestion.
AFB1 metabolism runs in two stages. The first stage comprises mainly the
transformation of AFB1 into AFB1 – 8,9-epoxide, while the second stage consist in the
conjugation of the epoxide with glutation, a major pathways of detoxification, followed by the
formation of the glucuronoconjugated and sulphurconjugated compounds (Guerre et al.,
1996). The biotransformations from the first stage occur mainly by substrate oxidation and
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less by substrate reduction. For AF and for a larger number of xenobiotics, the main
enzymatic system involved in these transformations is that of cytochrome P450. This
biotransformation route runs mainly in the hepatocytes, but it also takes place in a number of
different cell structures (Guerre et al., 1996).
We have also conducted mycotoxicological analyses on the incidence and amount of
mycotoxins in the bile. Thus, we analysed by ELISA for ZEA (LOD 0.275 ppb), 10 samples
of bile collected from bovids and a bile sample of bovid for AFB1 (ELISA, LOD 0.5 ppb) and
AF B2 (CSS, 1 ppb). The results were negative for all analyses, none of these mycotoxins
being detected using the specified methods.
About 90% of the blood AFB1 is in the plasma, the fraction associated to the proteins
being particularly bound to albumins. AF are oxidized in the liver with formation of very
reactive molecules, able to bind nucleic acids or functional proteins. This hepatic
bioactivation has an outstanding importance for animal health because of the reactive
metabolites that form in situ, at tissue level. AF metabolisation in the liver is done under the
action of the microsomal enzymes, the most active one being P450.
An experimental study which administered ZEA for 7 weeks (385-1925 ppb ZEA),
didn’t show any changes in the milk yield or the presence of ZEA residues in the milk, urine,
serum or tissues. α and β-zearalenol are derivatives of ZEA which are removed from the
animal organism through faeces and urine, and less (amounts in the range of μg/l) through the
milk. Of them, α-zearalenol is considered the metabolite with the strongest estrogenic activity.
Another ZEA metabolite, zeranol, has a strongly anabolysing effect. Both ZEA and its
metabolites are reabsorbed at the intestinal level, going through the entero-hepatic cycle
(Chinchila et al., 1998; Kennedy et al., 1995; Kennedy et al., 1998).
CONCLUSIONS
The analysis of the ruminal fluid samples by ELISA showed that the total AF were
determined in 100% cases (3 samples), with variation limits between 2.1 – 2.2 ppb in the
three analysed samples; AFB1 was determined in 100% cases (3 samples), with variation
limits between 0.98 – 0.99 ppb in the three analysed samples; - OTA was determined in 100%
cases (4 samples), with variation limits between 23.91 (non diluted sample) – 25.06 (the
sample diluted with distilled water).
The analysis of the 48 milk samples collected from bovids reared in 18 counties and
localities by ELISA for AFM1 showed the presence of the mycotoxin in 16.66% of the cases
(8 samples), with limits of variation between 0 - 42 ppt, while in 41.66% of the cases (40
samples) AFM1 was not detected by analysis.
The analysis by ELISA and CSS for ZEA and AFB1 of 10 samples of bile collected from
bovids, the results were negative for all analyses, none of these mycotoxins being detected
using the specified methods.
The presence of metabolites from aflatoxins, ochratoxin and zearalenone in various
biological fluids collected from bovids and the absence of maximal admitted loads requires a
continuous monitoring to assess their concentration in various biological matrices.
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